Ask Indegene Icon

Ask Indegene (Beta)

Online
🧠 Building on our previous conversation...

Hello, how can I help you today?

You may type your question or choose from the options below:

Explore Solutions
Browse Insights
View Case Studies
Read Latest News
Explore Careers
Connect with an Expert
Please enter your full name
Please enter a valid work email
Please enter your message

Thank you!

We'll be in touch. In the meantime, feel free to keep exploring!

#FutureReadyHealthcare
Indegene
Search Icon
Indegene’s hybrid concierge screening enrolls patients for trials ​
Home
What we think
Case studies

Indegene’s hybrid concierge screening enrolls patients for trials ​

The Customer

Client is a Japanese life sciences company with a strong track record in pharmaceuticals and medical device space. Client was looking for effective patient recruitment solutions for an ongoing lumbar disk herniation phase 3 trial

Challenges

  • Low conversion rate from primary to secondary patient screening impacted randomized recruitment targets​

    Sub-optimal engagement of qualified patients resulted in patient dropouts​

    Building confidence among potential participants during the screening process by providing them with appropriate, reliable and timely information about the trial study​

The Solution

We deployed our in-house Registered Nurses Concierge based in the US to develop and deploy a secondary screening program.


The trained nurses in respective therapy area facilitated empathetic and informative conversations, resulting in better engagement and improved experiences for volunteers who qualified primary screening.


With a callback time at less than 30 minutes post registration and primary screening, the concierge service enhanced reception and engagement while reducing patient dropouts.

Outcomes

The client received a steady and streamlined flow of patients for their phase 3 trial because of concierge-based secondary screening led by experts.

At a 16% conversion rate, we facilitated approximately 400 qualified patients from 2,500 primary screening qualified participants.

The deployment led to encouraging results in the pilot program such as contract extensions and 10x increased scope in secondary screening responsibilities.

0%

Conversion rate

0+

Primary screening qualified patients

0+

Qualified patients

Powered by Onetrust